<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="/images/favicon.png" type="image/x-icon">
  <title>Neurocutaneous Syndrome</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">
</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>
      
  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


    <h1>Neurocutaneous Syndrome</h1>
  
    <!-- <div class="author-flex">
      <div class="author-img">
        <img  src="/contributors/vt1.jpeg" alt="">
      </div>
      <div>
        <h2 class="name">Compiled by Victortayo</h2>
        <p class="updated">last updated, Nov 2022</p>
      </div>
    </div> -->

    <article class="notes">
        <a id='top'></a>
    <article>
    <!-- <h2 class='title'>Outline</h2> -->
    <div class="outline2">

      <input type="radio" name="control-2" id="show-2">
      <label for="show-2">Show Outline</label>
      <input type="radio" name="control-2" id="hide-2">
      <label for="hide-2">Hide Outline</label>
      <div class="contents">
         <ol>
            <li><a href="#header-1">Introduction</a></li>
            <li><a href="#header-2">Neurofibromatosis</a></li>
            <li><a href="#header-3">Tuberous Sclerosis (Bourneville‚Äôs Disease)</a></li>
            <li><a href="#header-4">Sturge-Weber Syndrome</a></li>
            <li><a href="#header-5">Klippel-Trenaunay-Weber Syndrome</a></li>
            <li><a href="#header-6">Von Hippel‚ÄìLindau Disease</a></li>
            <li><a href="#header-7">Ataxia Telangiectasia</a></li>
            <li><a href="#header-8">Incontinentia Pigmenti (Bloch-Sulzberger Disease)</a></li>
            <li><a href="#header-9">Hypomelanosis of Ito (Incontinentia Pigmenti Achromians)</a></li>
            <li><a href="#header-10">PHACE Syndrome</a></li>
         </ol>
      </div>
     <div>

      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li>These are heterogeneous group of disorders characterized by abnormalities of both the integument and central nervous system (CNS).</li>
                <li>Most are familial and believed to arise from a defect in differentiation of the primitive ectoderm.</li>
                <li>Some are sporadic.</li>
                <li>The term phakomatoses (phakomatosis from fkos, Greek for lentil) is reserved for a group of diseases in which the subject is predisposed to tumors of the skin, nervous system, and other organs.</li>
            </ul>
        </div>

      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Neurofibromatosis</a>
          </h2>
        </header>
        <div class='body'>
           <ul>
            <li>No longer considered to be a single disorder, neurofibromatosis has been divided into at least two genetically distinct forms.</li>
            <li>The common form, once known as peripheral neurofibromatosis, is called neurofibromatosis 1 (NF1) a.k.a Von Recklihausens Disease </li>
            <li>The other, termed central neurofibromatosis, is now called neurofibromatosis 2 (NF2).</li>
            <li>Segmental neurofibromatosis, in which the features of NF1 are confined to one part of the body.</li>
            <li>Spinal neurofibromatosis, characterized by the late appearance of spinal cord tumors, and marked by autosomal dominant caf√© au lait spots.</li>
           </ul>
          <section id='heading-2-1'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-1'>Neurofibromatosis 1</a>
              </h3>
            </header>
            <div class='body'>
               <ul>
                <li>This is characterized by multiple tumors within the central and peripheral nervous systems, cutaneous pigmentation, and lesions of the vascular system and viscera.</li>
                <li>Additionally, a tendency exists for a variety of tissues to undergo malignant transformation.</li>
                <li>The disease occurs in approximately 1 in 3,000 live births and is transmitted as a dominant trait with variable expression but virtually complete penetrance by the age of 5 years. </li>
                <li>No parental age effect occurs. </li>
                <li>It is the most common single-gene defect to affect the nervous system. </li>
                <li>Approximately one-half of the cases appear to be sporadic, and the mutation rate has been estimated at 1 in 10,000 gametes per generation, one of the highest mutation rates in humans.</li>
                <li>The gene for NF1 is located on the long arm of chromosome 17</li>
                <li>The gene encodes a cytoplasmic protein, named NEUROFIBROMIN.</li>
                <li>The NF1 gene is large and is intrinsically hypermutable; more than 100 mutations have been described.</li>
               </ul>

               <section id='heading-2-1-1'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-2-1-1'>Pathology</a>
                  </h4>
                </header>
                <div class='body'>
                    <ul>
                        <li>The most striking neuropathologic feature is the presence of tumors along the major peripheral nerves, with the ulnar and radial nerves being involved most frequently. </li>
                        <li>Neurofibromas are the most common type of tumors, but schwannomas also can be seen.</li>
                        <li>Tumors that are prone to develop within the CNS include primarily optic gliomas; pilocystic astrocytomas of the third ventricle, cerebellum, and spinal cord; and high-grade astrocytomas.</li>
                        <li>Additionally, neurofibromatosis has been associated with a number of other neoplastic processes with a greater than random frequency e.g  leukemia, Wilms tumor, neuroblastoma, and pheochromocytoma.</li>
                        <li>A syndrome of multiple endocrine neoplasia characterized by bilateral pheochromocytomas, medullary thyroid carcinoma, and multiple neuromas and caf√© au lait lesions has been delineated. </li>
                        <li>Although generally benign, both central and peripheral neurofibromas can undergo malignant degeneration.</li>
                    </ul>
        
                </div>
               </section>

               <section id='heading-2-1-2'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-2-1-2'>Clinical Manifestations</a>
                  </h4>
                </header>
                <div class='body'>
                    <ul>
                        <li>NF1 is a progressive disease process that can affect almost every organ.</li>
                        <li>When many peripheral lesions are present, few lesions tend to be within the CNS and vice versa.</li>
                        <li>Caf√©-au-lait spots are the hallmark of neurofibromatosis and are present in almost 100% of patients.</li>
                        <li>They are present at birth but increase in size, number, and pigmentation, especially during the first few years of life. </li>
                        <li>The spots are scattered over the body surface, with predilection for the trunk and extremities, with sparing of the face.</li>
                        <li>Various types of cutaneous tumors can be found. </li>
                        <li>The most characteristic for NF1 is the pedunculated molluscum fibrosum and the subcutaneous neurofibromas.</li>
                        <li>Generally, cutaneous tumors tend to enlarge slowly throughout life.</li>
                        <li>Plexiform neuromas can occur in all affected tissues and lead to hypertrophy of one or more extremity, exophthalmos, or defects of the skull and orbit.</li>
                        <li>Multiple nodules within the iris (iris hamartomas) were first described by Lisch. </li>
                        <li>Lisch nodules are seen in almost all affected individuals aged 21 or more years, but only in one-half of children aged 5 to 6 years.</li>
                        <li>Initially light colored, they become darker with time. Short stature is common</li>
                        <li>A large proportion of these children experiences growth hormone deficiency.</li>
                        <li>Skeletal abnormalities include low cervical or thoracic kyphoscoliosis, scalloping of the posterior portion of the vertebral bodies.</li>
                        <li>Hypertension can develop owing to the presence of a pheochromocytoma, it also can be the result of renal artery stenosis, the most common of a variety of arterial abnormalities seen in neurofibromatosis.</li>
                    </ul>

                    <figure>
                        <img src="../figures/ncs (1).jpg" alt="">
                        <figcaption>Multiple caf√© au lait </figcaption>
                      </figure>

                      <figure>
                        <img src="../figures/ncs (2).jpg" alt="">
                        <figcaption>Neurofibroma </figcaption>
                      </figure>

                      <figure>
                        <img src="../figures/ncs (3).jpg" alt="">
                        <figcaption>Axillary frecklins </figcaption>
                      </figure>

                      <figure>
                        <img src="../figures/ncs (4).jpg" alt="">
                        <figcaption>Plexiform neurofibroma </figcaption>
                      </figure>

                      <figure>
                        <img src="../figures/ncs (5).jpg" alt="">
                        <figcaption> Lisch nodules</figcaption>
                      </figure>

                      <figure>
                        <img src="../figures/ncs (6).jpg" alt="">
                        <figcaption>Multiple nodules </figcaption>
                      </figure>

                      <figure>
                        <img src="../figures/ncs (7).jpg" alt="">
                        <figcaption> Pseudoarthroses</figcaption>
                      </figure>

                      <figure>
                        <img src="../figures/ncs (8).jpg" alt="">
                        <figcaption>Bow legs and pseudoarthrosis </figcaption>
                      </figure>
                </div>
               </section>

               <section id='heading-2-1-3'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-2-1-3'>Neurologic manifestations</a>
                  </h4>
                </header>
                <div class='body'>
                    <ul>
                        <li>Can be grouped into five major categories: </li>
                        <ol>
                            <li>Cognitive Disabilities</li>
                            <li>Intracranial Tumors</li>
                            <li>Tumors of the Peripheral Nerves</li>
                            <li>Intraspinal Tumors</li>
                            <li>Cerebrovascular Accidents</li>
                        </ol>
                        <li>About 40% of children with neurofibromatosis have learning disabilities, only a small fraction have severe mental retarded.</li>
                        <li>Intracranial tumors can arise at any time of life, the optic pathway being the most common and the earliest site of involvement.</li>
                        <li>Approximately half of patients who harbor optic pathway tumors develop signs or symptoms such as proptosis and precocious puberty. </li>
                        <li>The latter is seen in approximately 40% of subjects and results from compression of the hypothalamus by the tumor.</li>
                        <li>The presence of precocious puberty in a child with NF1, therefore, should always arouse the suspicion of an enlarging intracranial tumor.</li>
                        <li>Tumors of the peripheral nerves can arise at any age and can involve any of the major nerves.</li>
                        <li>Even though these tumors are occasionally painful, surgical removal must be weighed carefully against the possibility of the procedure producing considerable neurologic deficit. </li>
                        <li>Malignant degeneration of neurofibromas occurs in less than 3% of children, but appears more frequently in adults.</li>
                        <li>Intraspinal tumors are generally slower to develop than intracranial tumors and asymptomatic spinal cord tumors are commonly detected on routine neuroimaging studies. </li>
                        <li>Cerebrovascular accidents are common and can be responsible for the abrupt evolution of neurologic signs.</li>
                    </ul>
        
                </div>
               </section>

               <section id='heading-2-1-4'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-2-1-4'>Diagnosis</a>
                  </h4>
                </header>
                <div class='body'>
                    <ul>
                        <li>DNA testing for the diagnosis of NF1 is limited, because present techniques detect only approximately 70% of mutations.</li>
                        <li>Prenatal diagnosis.</li>
                        <li>The diagnosis is still largely based on clinical criteria. The diagnostic criteria for NF1 are two or more of the following:</li>
                        <ol>
                            <li>Six or more caf√© au lait macules whose greatest diameter is more than 5 mm (prepubertal) and more than 15 mm (postpubertal). </li>
                            <li>Two or more neurofibromas of any type, or one or more plexiform neurofibroma</li>
                            <li>Freckling in the axillary or inguinal region</li>
                            <li>Optic glioma (tumor of the optic pathway)</li>
                            <li>Two or more Lisch nodules (iris hamartomas)</li>
                            <li>A distinctive osseous lesion such as sphenoid dysplasia or thinning of long bone cortex</li>
                            <li>A first-degree relative with NF1 according to the previously mentioned criteria.</li>
                        </ol>
                    </ul>
        
                </div>
               </section>

               <section id='heading-2-1-5'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-2-1-5'>Treatment and Prognosis</a>
                  </h4>
                </header>
                <div class='body'>
                    <ul>
                        <li>Therapy is symptomatic. </li>
                        <li>Multispecialist clinic at intervals of at least 6 months to 1 year to detect and manage the various potential complications. </li>
                        <li>Surgical removal of centrally located neoplasms is often lifesaving.</li>
                        <li>When tumors are confined to peripheral nerves, the long-term prognosis is generally good. </li>
                        <li>The prognosis for intracranial tumors depends on their location and whether they are single or multiple. </li>
                    </ul>
        
                </div>
               </section>
            </div>
          </section>

          <section id='heading-2-2'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-2'>Neurofibromatosis 2</a>
              </h3>
            </header>
            <div class='body'>
               <ul>
                <li>Genetically and clinically distinct from NF1.</li>
                <li>Less common and it is characterized by the development of CNS tumors, notably bilateral vestibular schwannomas.</li>
                <li>The gene for NF2 has been mapped to the long arm of chromosome 22 (22q11).</li>
                <li>Its gene product, merlin (schwannomin), shares significant homology with several actin-associated proteins.</li>
               </ul>

               <h4>Merlin</h4>
               <ul>
                <li>A tumor suppressor which plays a role in the regulation of cell-cell adhesion, and in the reorganization of the actin cytoskeleton in response to growth factors, confluency, and changes in the shape of the cell.</li>
                <li>Merlin is absent from almost all schwannomas and from many meningiomas and ependymomas isolated from subjects with NF2.</li>
               </ul>


               <section id='heading-2-2-1'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-2-2-1'>Clinical Manifestations</a>
                  </h4>
                </header>
                <div class='body'>
                    <ul>
                        <li>The clinical manifestations of NF2 are highlighted by the presence of bilateral vestibular schwannomas (acoustic neuromas), which become manifest in more than 95% of genetically affected subjects. </li>
                        <li>Generally, these tumors become symptomatic at puberty or thereafter.</li>
                        <li>In addition, schwannomas occur in the other cranial nerves and the spinal and cutaneous nerves.</li>
                        <li>Other tumors of the CNS seen in this condition include cranial and spinal meningiomas and multiple tumors of glial and meningeal origin.</li>
                        <li>Caf√© au lait lesions are less common.</li>
                        <li>Cataracts (posterior subcapsular or cortical)  </li>
                        <li>Seizures.</li>
                        <li>Peripheral nerve tumors predominantly schwannomas, or neurofibromas. </li>
                        <li>Other skin lesions such as nodular tumors or neurofibromas also are less common than in NF1. </li>
                    </ul>
        
                </div>
              </section>

              <section id='heading-2-2-2'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-2-2-2'>Diagnosis</a>
                  </h4>
                </header>
                <div class='body'>
                    <p>The criteria for NF2 are one or more:</p>
                    <ul>
                        <li>Bilateral eighth nerve masses (vestibular schwannomas) </li>
                        <li>A parent, sibling, or child with NF2 and either unilateral eighth nerve mass or any two of the following conditions:</li>
                        <ul>
                            <li>Neurofibroma,</li>
                            <li>Meningioma, </li>
                            <li>Glioma, </li>
                            <li>Schwannoma,</li>
                            <li>Juvenile posterior subcapsular lenticular opacity</li>
                        </ul>
                    </ul>
                </div>
              </section>
            </div>
          </section>

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Tuberous Sclerosis (Bourneville‚Äôs disease)</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li>Tuberous sclerosis or tuberous sclerosis complex (TSC) is a rare, multi-system genetic disease that causes benign tumours to grow in the brain and on other vital organs such as the kidneys, heart, eyes, lungs, and skin. </li>
                <li>Approximately one-third of cases are familial, and the rest are new mutations.</li>
                <li>A combination of symptoms may include seizures, developmental delay, behavioural problems, skin abnormalities, lung and kidney disease. </li>
                <li>It occurs with a frequency of 1 in 6,000 to 15,400 and is transmitted as an autosomal dominant gene.</li>
                <li>It is genetically heterogeneous, with loci on chromosome 9q (TSC1), and 16p (TSC2). </li>
                <li>Each locus accounts for approximately 50% of familial cases.</li>
                <li>TSC1 codes for HAMARTIN, a 130-kd protein with no significant homology to any other known vertebrate protein. </li>
                <li>TSC2 codes for TUBERIN, a 200-kd protein, which functions as a tumor-suppressor gene.</li>
            </ul>
            
            <section id='heading-3-1'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-1'>Pathology</a>
                  </h3>
                </header>
                <div class='body'>
                   <ul>
                    <li>The most characteristic gross abnormality is the presence of tubers.</li>
                    <li>These are numerous hard areas of gliotic tissue of varying size, after which this condition is named.</li>
                    <li>On histologic examination they are sclerotic areas that consist of an overgrowth of atypical giant astrocytes, and groups of large, bizarre, and frequently vacuolated ‚Äúmonster cells.‚Äù</li>
                    <li>Blood vessels in sclerotic regions show hyaline degeneration of their walls.</li>
                    <li>In approximately half of subjects, calcium is deposited within the gliotic areas to an extent as to be visible on plain radiography of the skull or on computed tomographic (CT) scanning. </li>
                    <li>Subependymal nodules found in the ventricular walls, particularly in the region of the foramen of Monro are multiple small, tumor-like nodules that project into the ventricles and, because of their appearance on pneumoencephalography were described as ‚Äúcandle drippings.‚Äù</li>
                   </ul>

                   <h4>Pathophysiology</h4>
                   <ul>
                    <li>Hamartin and tuberin function as a complex which is involved in the control of cell growth and cell division. </li>
                    <li>Thus, mutations at the TSC1 and TSC2 loci result in a loss of control of cell growth and cell division, and therefore a predisposition to forming tumors.</li>
                   </ul>
                </div>
            </section>

            <section id='heading-3-2'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-2'>Clinical manifestations</a>
                  </h3>
                </header>
                <div class='body'>
                   <ul>
                    <li>TSC affects tissues from different germ layers.</li>
                    <li>Cutaneous and visceral lesions may occur, including adenoma sebaceum, cardiac rhabdomyomas, and renal angiomyolipomas.</li>
                    <li>The central nervous system (CNS) lesions seen in this disorder include hamartomas of the cortex, ventricular walls, and subependymal giant cell tumors, which typically develop in the vicinity of the foramina of Monro.</li>
                    <li>Manifestations of TS vary considerably with respect to age of onset, severity, and rate of progression. </li>
                   </ul>
                   <p>The four main types of manifestations are</p>
                   <ol>
                    <li>Mental retardation,</li>
                    <li>Seizures, </li>
                    <li>Cutaneous lesions,</li>
                    <li>Tumors in various organs including the brain.</li>
                   </ol>
                   <ul>
                    <li>Mental retardation may often due to poor seizure control.</li>
                    <li>Commonest seizures in them is infantile spasm.</li>
                    <li>Cutaneous manifestation include adenoma sebaceum, shagreen patch, ash leaf macules</li>
                    <li>Tumors </li>
                    <li>Adenoma sebaceum (angiofibroma) consist of a red, papular rash over the nose, chin, cheeks, and malar region, appearing between ages 1 and 5 years.</li>
                    <li>Depigmented nevi (ash leaf), are oval areas with irregular margins over the trunk and extremities are equally common.</li>
                    <li>They are more readily visualized when the skin is illuminated with ultraviolet light (Wood lamp). </li>
                    <li>Generally, they appear earlier than the adenoma sebaceum. </li>
                    <li>They can be noted at birth and are seen before 2 years of age in more than one-half of the subject</li>
                    <li>Ash leaf macules differ from vitiligo in that in vitiligo the melanocytes are absent, whereas in depigmented macules the melanocytes are normal, but the melanosomes are reduced and contain less melanin. </li>
                    <li>Of the other cutaneous abnormalities, flattened fibromas are the most common.</li>
                    <li>They appear in a variety of areas, including the trunk, gingivae, and periungual regions.</li>
                    <li>In some infants, fibromas are found along the hairline or eyebrows.</li>
                    <li>Shagreen patch. This is an uneven thickening of skin, grayish green or light brown, raised above the surrounding surface, usually in the posterior lumbosacral region.</li>
                    <li>Caf√© au lait spots are seen in 7% to 16% of subjects.</li>
                   </ul>

                   <figure>
                    <img src="../figures/ncs (1).png" alt="">
                    <figcaption>Cutaneous Manifestations Pictures   </figcaption>
                  </figure>

                  <figure>
                    <img src="../figures/ncs (9).jpg" alt="">
                    <figcaption> Adenoma sebaceum</figcaption>
                  </figure>

                  <figure>
                    <img src="../figures/ncs (11).jpg" alt="">
                    <figcaption>Ashleaf macules </figcaption>
                  </figure>

                  <figure>
                    <img src="../figures/ncs (10).jpg" alt="">
                    <figcaption>Intracranial tumors  </figcaption>
                  </figure>

                  <ul>
                    <li>Intracranial tumors are less frequent in TS than in neurofibromatosis.</li>
                    <li>Although the numerous intraventricular nodules are technically tumors, they usually do not grow to the extent of producing increased intracranial pressure.</li>
                    <li>Tumors are found in the neighborhood of the foramen of Monro, arising from either the walls of the lateral ventricles or the anterior portion of the third ventricle.</li>
                    <li>On the basis of their histology, they have been classified as giant cell astrocytomas</li>
                  </ul>
                </div>
            </section>

            <section id='heading-3-3'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-3'>Diagnosis</a>
                  </h3>
                </header>
                <div class='body'>
                   <ul>
                    <li>The diagnosis of TS is based on the characteristic skin lesions, seizures, and intellectual impairment or deterioration. </li>
                    <li>In infants, the combination of depigmented areas of skin, infantile spasms, and delayed development is diagnostic.</li>
                    <li>Diagnostic Criteria for Tuberous Sclerosis Complex has also been proposed.</li>
                   </ul>

                   <h4>Proposed diagnostic criteria</h4>
                   <p>The various signs are then marked against the diagnostic criteria to produce a level of diagnostic certainty:</p>
                   <ul>
                    <li>Definite ‚Äì Either two major features or one major feature plus two minor features.</li>
                    <li>Probable ‚Äì One major plus one minor feature.</li>
                    <li>Suspect ‚Äì Either one major feature or two or more minor features.</li>
                   </ul>

                   <figure>
                    <img src="../figures/ncs (14).png" alt="">
                    <figcaption> Major Criteria</figcaption>
                  </figure>

                  <figure>
                    <img src="../figures/ncs (15).png" alt="">
                    <figcaption> Minor Criteria</figcaption>
                  </figure>
                </div>
            </section>

            <section id='heading-3-4'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-4'>Management</a>
                  </h3>
                </header>
                <div class='body'>
                <ul>
                    <li>DETAILED  HISTORY‚Äî personal and family.</li>
                    <li>DETAILED EXAMINATION  </li>
                    <li>The skin for Shagreen patch under a Wood's lamp (Ash leaf macules),</li>
                    <li>The fingers and toes (ungual fibroma), </li>
                    <li>The face (angiofibromas) and </li>
                    <li>The mouth (dental pits and gingival fibromas).</li>
                    <li>INVESTIGATIONS‚Äî Cranial imaging with non-enhanced CT or, preferably, MRI (cortical tubers and subependymal nodules).</li>
                    <li>Renal ultrasound (angiomyolipoma or cysts).</li>
                    <li>An echocardiogram in infants (rhabdomyoma).</li>
                    <li>Fundoscopy (retinal nodular hamartomas or achromic patch).</li>
                </ul>
                </div>
            </section>

            <section id='heading-3-5'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-5'>Treatment and prognosis</a>
                  </h3>
                </header>
                <div class='body'>
                   <ul>
                    <li>No specific treatment is available. </li>
                    <li>Seizures are managed with anticonvulsant medications.</li>
                    <li>In selected patients, resection of a single cortical epileptogenic tuber by stereotactic techniques or open craniotomy can result in a marked reduction of seizure frequency.</li>
                    <li>Role of RAPAMYCIN: Various investigators have also proved that topically applied rapamycin causes regression of facial angiofibromas, giving better cosmetic results.</li>
                    <li>Resection of intraventricular tumors is reserved for children who develop ventricular obstruction.</li>
                    <li>Regular neurologic examinations of the patient with TS should be carried out.</li>
                   </ul>
                </div>
            </section>
              
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Sturge-Weber Syndrome</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li>Sporadic condition characterized by a port-wine vascular nevus on the upper part of the face, saltatory neurologic deterioration, and eventual neurodevelopmental delay. </li>
                <li>The hallmark intracranial vascular anomaly is a leptomeningeal angiomatosis that involves one or more lobes in one or both hemispheres.   </li>
            </ul>
            <div class="tips-card">
                <p class="tips-card-subtitle">note</p>
                <h4 class="tips-card-title">
                </h4>
                <p class="tips-card-content">
                  <ul>
                    <li>Although a port-wine stain on the face is a relatively common malformation, occurring in approximately 3 in 1,000 births, only 5% of infants affected with this type of a cutaneous lesion have SWS. </li>
                    <li>13% of patients with cerebral manifestations of SWS do not have a facial nevus.</li>
                  </ul>
                    
                </p>
              </div>


            <section id='heading-4-1'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-1'>Pathogenesis/ Pathology</a>
                  </h3>
                </header>
                <div class='body'>
                   <ul>
                    <li>Malformation of an embryonic vascular plexus.</li>
                    <li>Basis of abnormalities of the skin, cortex, leptomeninges, and choroid. </li>
                    <li>5 to 8 weeks of gestation </li>
                    <li>On pathologic examination of the brain, the essential feature is a leptomeningeal angiomatosis with a predilection for the occipital or occipitoparietal region of one cerebral hemisphere.</li>
                    <li>On microscopic examination the walls of these vessels are encrusted with iron and calcium deposits. </li>
                    <li>Cortical calcifications usually are found in the degenerated cortex underneath the vascular malformations.</li>
                   </ul>
                </div>
            </section>

            <section id='heading-4-2'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-2'>Clinical Manifestations</a>
                  </h3>
                </header>
                <div class='body'>
                   <ul>
                    <li>SWS is a progressive disease. </li>
                    <li>The cutaneous port-wine nevus is present at birth and involves at least one eyelid or the supraorbital region of the face.</li>
                    <li>An angioma of the choroid membrane of the eye is often associated with unilateral congenital glaucoma and buphthalmos.</li>
                    <li>Up to 90% of may develop focal or generalized seizures.</li>
                    <li>These are usually the initial neurologic manifestation and frequently begin in the first year of life.</li>
                    <li>Seizures can progressively become more refractory to medication and can be followed by transient or permanent hemiparesis. </li>
                    <li>Hemiparesis, often with homonymous hemianopia,</li>
                    <li>Glaucoma can be present at birth or develop over the years in up to 60% of patients.</li>
                    <li>Less commonly, symptoms owing to hemangiomas involve the viscera e.g  hematuria and gastrointestinal hemorrhages. </li>
                    <li>Intracranial hemorrhages are rare.</li>
                   </ul>
                </div>
            </section>

            <section id='heading-4-3'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-3'>Diagnosis</a>
                  </h3>
                </header>
                <div class='body'>
                   <ul>
                    <li>Often, the coexistence of a facial vascular nevus and seizures should suggest SWS.</li>
                    <li>MRI is presently the diagnostic modality of choice.</li>
                    <li>Characteristically, calcifications are arranged in parallel lines (‚Äúrailroad tracks‚Äù) or serpentine convolutions that are most striking in the occipital and parieto-occipital areas.</li>
                    <li>Double contoured curvilinear sign.</li>
                   </ul>
                </div>
            </section>

            <section id='heading-4-4'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-4'>Treatment and Prognosis</a>
                  </h3>
                </header>
                <div class='body'>
                   <p>Multi specialists </p>
                   <ul>
                    <li>Ophthalmologic consultation should be obtained, management of glaucoma.</li>
                    <li>Some children have rare complex partial seizures, but in the context of SWS, carbamazepine should be initiated after the first seizure.</li>
                    <li>Neurosurgeon ‚Äì lobectomy/hemispherectomy</li>
                   </ul>
                </div>

                <figure>
                    <img src="../figures/ncs (12).jpg" alt="">
                    <figcaption> </figcaption>
                </figure>

                <figure>
                    <img src="../figures/ncs (2).png" alt="">
                    <figcaption>Port wine stain </figcaption>
                  </figure>

                  <figure>
                    <img src="../figures/ncs (3).png" alt="">
                    <figcaption>Lateral X-ray of the skull showing the typical gyriform calcification, 'tram-track' calcification, and enlargement of the paranasal sinuses </figcaption>
                  </figure>

                  <figure>
                    <img src="../figures/ncs (4).png" alt="">
                    <figcaption>CT scan showing extensive gyriform calcification in the right parieto-occipital region with ipsilateral cerebral cortical atrophy.	 </figcaption>
                  </figure>

            </section>
        </div>
      </section>



      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Klippel-Trenaunay-Weber Syndrome</a>
          </h2>
        </header>
        <div class='body'>
           <ul>
            <li>A close differential diagnosis of SWS.</li>
            <li>Nonhereditary </li>
            <li>Consists of cutaneous vascular nevi, which can appear at any site of the body and vary in size, venous varicosities, and hypertrophy of the bone and soft tissues.  </li>
            <li>In some instances, the syndrome is associated with seizures, facial hemihypertrophy, and intracerebral calcifications.</li>
           </ul>

           <figure>
                    <img src="../figures/ncs (5).png" alt="">
                    <figcaption> </figcaption>
           </figure>

           <figure>
                    <img src="../figures/ncs (6).png" alt="">
                    <figcaption> </figcaption>
            </figure>
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Von Hippel‚ÄìLindau Disease </a>
          </h2>
        </header>
        <div class='body'>
           <ul>
            <li>The association of cerebellar hemangioblastomas with angiomas of the spinal cord, multiple congenital cysts of the pancreas, and kidney and renal carcinoma was first recorded by Lindau in 1926.</li>
            <li>Autosomal dominant trait with variable penetrance.</li>
            <li>Prevalence is 1 in 40,000 to 50,000</li>
            <li>The von Hippel‚ÄìLindau (VHL) gene has been localized to the tip of the short arm of chromosome 3 and codes for two different tumor-suppressor proteins.</li>
            <li>Symptoms are often delayed until the second or third decade and can be referred to the eye with sudden intraocular hemorrhage, or to the posterior fossa with increased intracranial pressure or cerebellar signs. </li>
            <li>Most commonly, the neoplasm is located in the cerebellum.</li>
            <li>It can be found in the spinal cord in 44% and in the brainstem in 18% of patients with CNS hemangioblastoma.</li>
            <li>A high CSF protein content is seen in the majority of subjects, and approximately 50% of patients with cerebellar tumors have polycythemia, the consequence of erythropoietin production by the tumor. </li>
           </ul>
        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'>Ataxia telangiectasia </a>
          </h2>
        </header>
        <div class='body'>
           <ul>
            <li>AT is characterized by slowly progressive cerebellar ataxia, choreoathetosis, telangiectasis of the skin and conjunctivae, and susceptibility to sinobronchopulmonary infections, lymphoreticular neoplasia, and other malignancies.</li>
            <li>The gene for AT has been mapped to the long arm of chromosome 11. It codes for a large phosphoprotein.</li>
            <li>These proteins are involved in the cellular responses to DNA damage, cell-cycle control, and maintaining telomere length.</li>
           </ul>

           <section id='heading-7-1'>
            <header>
              <h3>
                <a aria-hidden href='#heading-7-1'>Clinical Manifestations</a>
              </h3>
            </header>
            <div class='body'>
               <ul>
                <li>Cerebellar signs appear in infancy or early childhood.</li>
                <li>The telangiectases, which are characteristically located over the exposed areas, bulbar conjunctivae, bridge of the nose, ears, neck, and antecubital fossae, first seen at between 3 and 10 years of age and become more marked with exposure to sunlight.</li>
                <li>Thinning and premature graying of the hair and loss of skin elasticity and subcutaneous fat also are prominent. </li>
                <li>Approximately 85% of patients develop choreoathetosis, and nystagmus. </li>
                <li>Hypotonia, diminished reflexes, and generalized muscular weakness also have been observed and occur later.</li>
                <li>Intelligence usually becomes impaired as the illness progresses. </li>
                <li>Most patients experience recurrent sinopulmonary infections. </li>
                <li>Neoplastic disease is common. </li>
                <li>In particular, children with AT are 40 to 100 times more likely to develop lymphoma, leukemia, lymphosarcoma, and Hodgkin's disease than their peers.</li>
                <li>Oculocutaneous lesions and the neurologic picture particularly the oculomotor apraxia fully developed are almost diagnostic. </li>
                <li>Progressive cerebellar ataxia.</li>
               </ul>
            </div>
          </section>

          <section id='heading-7-2'>
            <header>
              <h3>
                <a aria-hidden href='#heading-7-2'>Investigation</a>
              </h3>
            </header>
            <div class='body'>
               <ul>
                <li>Elevated serum a-fetoprotein (up to 95% of patients).</li>
                <li>Elevated carcinoembryonic antigen nearly all patients.</li>
                <li>IgE concentrations are usually low, and the IgM may be of the low molecular weight variety. </li>
                <li>IgG2 or total IgG levels may be decreased</li>
                <li>The most frequent humoral immunologic abnormality is the selective absence of IgA, which is present in 50‚Äì80% of these patients.</li>
                <li>Hypercatabolism of IgA also occurs.</li>
               </ul>

               <h4>Diagnosis</h4>
               <ul>
                <li>The characteristic defect in serum immunoglobulins, impaired delayed hypersensitivity responses, and the demonstration of spontaneous chromosome breaks also can assist in the diagnosis. </li>
                <li>Prenatal diagnosis of the disease by genotype analysis is also possible.</li>
               </ul>
            </div>
          </section>

          <section id='heading-7-3'>
            <header>
              <h3>
                <a aria-hidden href='#heading-7-3'>Treatment</a>
              </h3>
            </header>
            <div class='body'>
               <ul>
                <li>No specific treatment prevents the neurologic progress of AT. </li>
                <li>Intercurrent sinopulmonary infections can be prevented by gamma globulin therapy or treated with antibiotics and postural drainage.</li>
               </ul>
            </div>
          </section>
        </div>
      </section>

      <section id='header-8'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-8'>Incontinentia Pigmenti (Bloch-Sulzberger Disease) </a>
          </h2>
        </header>
        <div class='body'>
           <ul>
            <li>This rare, heritable, multisystem ectodermal disorder features dermatologic, dental, and ocular abnormalities.</li>
            <li>X-linked dominant gene that is lethal in males.</li>
            <li>The paucity of affected males, the occurrence of female-female transmission in keeping.</li>
            <li>The gene nuclear factor is located at Xq28.</li>
            <li>Nuclear factor kappa B Essential Modulator (NEMO).</li>
           </ul>

           <section id='heading-8-1'>
            <header>
              <h3>
                <a aria-hidden href='#heading-8-1'>Clinical manifestations (4 phases)</a>
              </h3>
            </header>
            <div class='body'>
               
              <h4>First phase</h4>
              <ul>
                <li>First few weeks of life:</li>
                <li>Consists of erythematous linear streaks and plaques of vesicles that are most pronounced on the limbs and circumferentially on the trunk.</li>
                <li>Linear configuration is unique. </li>
                <li>Histopathologically, epidermal edema and eosinophil-filled intraepidermal vesicles are present. </li>
                <li>Eosinophils also infiltrate the adjacent epidermis and dermis.</li>
                <li>Blood eosinophilia up to 65% also is common.</li>
                <li>The first stage generally resolves by 4 month of age.</li>
              </ul>

              <h4>Second phase</h4>
              <ul>
                <li>As blisters on the distal limbs resolve, they become dry and hyperkeratotic, forming verrucous plaques. </li>
                <li>The verrucous plaques rarely affect the trunk or face and generally involute within 6 mo.</li>
                <li>Epidermal hyperplasia, hyperkeratosis, and papillomatosis are characteristic.</li>
              </ul>

              <h4>The third or pigmentary phase</h4>
              <ul>
                <li>It is the hallmark of incontinentia pigmenti.</li>
                <li>It generally develops over weeks to months and may overlap the earlier phases, be evident at birth, or, more commonly, begin to appear within the first few weeks of life. </li>
                <li>Hyperpigmentation more often is apparent on the trunk than the limbs and is distributed in macular whorls, reticulated patches, flecks, and linear streaks that follow Blaschko lines.</li>
                <li>The axillae and groin are invariably affected.</li>
                <li>The sites of involvement are not necessarily those of the preceding vesicular and warty lesions. </li>
                <li>The pigmented lesions, once present, persist throughout childhood.</li>
                <li>They generally begin to fade by early adolescence, however, and often have disappeared by age 16 yr.</li>
              </ul>

              <h4>Fourth phase</h4>
              <ul>
                <li>Hypopigmented, hairless, anhidrotic patches or streaks occur as a late manifestation, they may develop, however, before the hyperpigmentation of stage three has resolved. </li>
                <li>The lesions develop mainly on the flexor aspect of the lower legs and less often on the arms and trunk.</li>
              </ul>
            </div>
          </section>

          <section id='heading-8-2'>
            <header>
              <h3>
                <a aria-hidden href='#heading-8-2'>Diagnosis</a>
              </h3>
            </header>
            <div class='body'>
               <p>Diagnosis is made on clinical grounds, although major and minor criteria have been established to aid in diagnosis.</p>

               <figure>
                <img src="../figures/ncs (7).png" alt="">
                <figcaption> </figcaption>
              </figure>

              <figure>
                <img src="../figures/ncs (8).png" alt="">
                <figcaption> </figcaption>
              </figure>

              <figure>
                <img src="../figures/ncs (9).png" alt="">
                <figcaption> </figcaption>
              </figure>
            </div>
          </section>
        </div>
      </section>

      <section id='header-9'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-9'>Hypomelanosis of Ito (Incontinentia Pigmenti Achromians) </a>
          </h2>
        </header>
        <div class='body'>
           <ul>
            <li>Affects children of both sexes and is frequently associated with defects in several organ systems. </li>
            <li>There is no evidence for genetic transmission; chromosomal mosaicism and chromosomal translocations have been reported.</li>
            <li>Generally present at birth but may be acquired within the first 2 yr of life.</li>
           </ul>

           <section id='heading-9-1'>
            <header>
              <h3>
                <a aria-hidden href='#heading-9-1'>Manifestations</a>
              </h3>
            </header>
            <div class='body'>
               <ul>
                <li>Consists of bizarre, patterned, hypopigmented macules arranged over the body surface in sharply demarcated whorls, streaks, and patches that follow the lines of Blaschko.</li>
                <li>The palms, soles, and mucous membranes are spared. </li>
                <li>The hypopigmentation remains unchanged throughout childhood but fades during adulthood.</li>
               </ul>

               <div class="tips-card">
                <p class="tips-card-subtitle">note</p>
                <h4 class="tips-card-title">
                  The Blaschko line (Alfred Blaschko)
                </h4>
                <p class="tips-card-content">
                  <ul>
                    <li>Large numbers of nevoid diseases or acquired dermatosis are arranged along line in Blaschko line. </li>
                    <li>This line is different from the dermatome.</li>
                    <li>It does not run along the blood vessel or the lymph duct. </li>
                    <li>According to the recent knowledge, Blaschko line indicates that epidermal cells and adnex cells constituting the skin proliferate and expand along this line.</li>
                    <li>A pattern of distribution of skin lesions or pigmentary anomalies; linear on the extremities, S-shaped curves on the abdomen, and V-shaped on the back; thought to result from genetic mosaicism and the interplay of transverse clonal proliferation and longitudinal growth and flexion of the embryo.</li>
                  </ul>
                </p>
              </div>

              <ul>
                <li>The most commonly associated abnormalities involve the nervous system, including </li>
                <ul>
                  <li>Mental retardation (70%), </li>
                  <li>Seizures (40%),</li>
                  <li>Microcephaly (25%), </li>
                  <li>Muscular hypotonia (15%). </li>
                  <li>Macrocephaly (23%)</li>
                </ul>
                <li>The musculoskeletal system is the second most frequently involved system, affected by scoliosis and thoracic and limb deformities.</li>
                <li>Hemihypertrophy </li>
                <li>Minor ophthalmologic defects (strabismus, nystagmus) are present in 25% of patients, and 10% have cardiac defects.</li>
              </ul>

              <figure>
                <img src="../figures/ncs (10).png" alt="">
                <figcaption> </figcaption>
              </figure>

              <figure>
                <img src="../figures/ncs (11).png" alt="">
                <figcaption> </figcaption>
              </figure>

              <figure>
                <img src="../figures/ncs (12).png" alt="">
                <figcaption> </figcaption>
              </figure>

              <figure>
                <img src="../figures/ncs (13).png" alt="">
                <figcaption>Line of Blaschko </figcaption>
              </figure>
            </div>
          </section>
        </div>
      </section>

      <section id='header-10'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-10'>PHACE Syndrome</a>
          </h2>
        </header>
        <div class='body'>
          <ul>
            <li>Posterior fossa malformations, </li>
            <li>Hemangiomas, </li>
            <li>Arterial anomalies, </li>
            <li>Coarctation of the aorta and other cardiac defects, and </li>
            <li>Eye abnormalities.  </li>
          </ul>

          <figure>
            <img src="../figures/ncs (13).jpg" alt="">
            <figcaption> Segmental Haemangioma in PHACE syndrome</figcaption>
          </figure>

          <ul>
            <li>There is a female predominance.</li>
            <li>Airway hemangiomas may produce obstruction.</li>
            <li>Interferon-a is of value in the management of the hemangiomas.</li>
          </ul>
        </div>
      </section>



      
      </section>

      <div class="contact">
        <hr style="margin: 3rem 0;">

        <div class="comment">
        <p>Send your comments, corrections, explanations/clarifications and requests/suggestions to our <a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">WhatsApp group</a>.</p>
        </div>
      </div>
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The content on this ‚ÄòWebsite‚Äô, including but not limited to text, graphics, images, videos, and other materials, should not be considered as a substitute for formal medical education or clinical training. The creators and operators of this Website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the Website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this Website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>     
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
          <p><a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">say hiüëã</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
</body>
</html>
 
